TABLE 2A.
Number | Strain | Accession number | Remarks |
MIC (μg/mL) |
|||
1a | 2b | AMPc | NORd | ||||
1 | Bacillus sp. | CCARM 9248 | 64 | 8 | 16 | 0.12 | |
2 | Bacillus cereus | CCARM 0002 | 128 | 128 | 8 | 1 | |
3 | Enterococcus faecalis | CCARM 5171 | susceptible | >128 | >128 | 2 | 1 |
4 | Enterococcus faecalis | CCARM 5025 | VREe (vanB) | >128 | >128 | 2 | 2 |
5 | Enterococcus faecium | CCARM 5024 | VREe (vanA) | 0.5 | 1 | 32 | 4 |
6 | Staphylococcus aureus | CCARM 0205 | susceptible | 32 | 64 | 2 | 1 |
7 | Staphylococcus aureus | CCARM 3855 | susceptible | >128 | >128 | 0.25 | 1 |
8 | Staphylococcus aureus | CCARM 3089 | MDRf | >128 | >128 | 64 | 128 |
9 | Escherichia coli | CCARM 0230 | >128 | >128 | 2 | 0.03 | |
10 | Escherichia coli | CCARM 0237 | >128 | >128 | 8 | 0.5 | |
11 | Escherichia coli | CCARM 0235 | >128 | >128 | 4 | 0.06 | |
12 | Pseudomonas aeruginosa | CCARM 0219 | >128 | >128 | >128 | 1 | |
13 | Pseudomonas aeruginosa | CCARM 0223 | >128 | >128 | >128 | 0.5 | |
14 | Pseudomonas aeruginosa | CCARM 0225 | >128 | >128 | 0.5 | 0.25 | |
15 | Salmonella Typhimurium | CCARM 0240 | >128 | >128 | 1 | 0.06 | |
16 | Enterobacter cloacae | CCARM 0252 | >128 | >128 | >128 | 0.06 | |
17 | Enterobacter cloacae | CCARM 0253 | >128 | >128 | 1 | 0.03 | |
18 | Klebsiella oxytoca | CCARM 0248 | >128 | >128 | >128 | 0.03 | |
19 | Klebsiella aerogenes | CCARM 0249 | >128 | >128 | 2 | 0.06 | |
20 | Escherichia coli | ATCC 25922 | QCg strain | >128 | >128 | 4 | 0.06 |
21 | Enterococcus faecalis | ATCC 29212 | QCg strain | >128 | >128 | 0.5 | 2 ∼ 8 |
22 | Enterococcus faecium | ATCC 19434 | QCg strain | 16 | 8 | 0.5 | – |
23 | Pseudomonas aeruginosa | ATCC 27853 | QCg strain | >128 | >128 | >128 | 1 ∼ 4h |
24 | Staphylococcus aureus | ATCC 29213 | QCg strain | >128 | >128 | 0.13 | 0.5 ∼ 2h |
25 | Salmonella enteric | ATCC 14028 | QCg strain | 128 | 128 | 0.13 | – |
26 | Klebsiella pneumoniae | ATCC 10031 | QCg strain | >128 | >128 | 32 | – |
a lenzimycin A, blenzimycin B, cAmpicillin, dNorfloxacin, eVancomycin-resistant Enterococci, fMultiple drug resistance, gQuality control, and hAcceptable range.